| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Dissemination and evaluation of the ASAS/EULAR recommendations for the management  of ankylosing spondylitis: results of a study among 1507 rheumatologists Gossec L; Dougados M; Phillips C; Hammoudeh M; de Vlam K; Pavelka K; Pham T; Braun J; Sieper J; Olivieri I; van der Heijde D; Collantes E; Stone M; Kvien TKAnn Rheum Dis  2008[Jun]; 67 (6): 782-8BACKGROUND: Ten ASAS/EULAR recommendations for the management of ankylosing  spondylitis (AS) were published in 2006. OBJECTIVES: (a) To disseminate and (b)  to evaluate conceptual agreement with, and (c) application of, these  recommendations as well as (d) potential barriers to the application. METHODS: A  questionnaire was sent to rheumatologists in 10 countries. It included (a) the  text of the recommendations; (b) rheumatologists' demographic variables; (c) two  numerical rating scales from 1 to 10 for each recommendation: conceptual  agreement with, and application of, the recommendation (10 indicates maximal  agreement and maximal application); and (d) a list of potential barriers to the  application of the recommendation. Statistical analysis included descriptive and  multivariate analyses. RESULTS: 7206 questionnaires were sent out; 1507 (21%)  were returned. Of the 1507 answering rheumatologists, 62% were men, mean (SD) age  49 (9) years, and 34% had an academic position. Conceptual agreement with the  recommendations was high (mean (SD) for all recommendations 8.9 (0.9)).  Self-reported application was also high (8.2 (1.0)). The difference between  agreement and application varied across recommendations and countries. The most  pronounced discrepancies were reported for use of anti-tumour necrosis factor  drugs in a few countries, with funding as the most commonly reported barrier for  application of this recommendation. CONCLUSION: This large project has helped the  dissemination of the ASAS/EULAR recommendations for the management of AS and  shows that conceptual agreement with the recommendations is very high. The  project also highlights inequalities in access to healthcare for European  citizens with AS.|*Consensus[MESH]|*Practice Guidelines as Topic[MESH]|*Rheumatology[MESH]|Adult[MESH]|Europe[MESH]|Humans[MESH]|Male[MESH]|Middle Aged[MESH]|Spondylitis, Ankylosing/*therapy[MESH]
 |